Class IICompletedD-0692-2021
Drug recall · July 28, 2021
Compounded Lyophilized Semorelin/Ipamorelin 3 mg For subcutaneous or intramuscular injection recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Compounded Lyophilized Semorelin/Ipamorelin 3 mg For subcutaneous or intramuscular injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910
- Lots / codes
Lot #: SIP215 Exp. 01/14/2022, SIP220 Exp. 01/23/2022, SIP210 Exp. 12/15/2021
- Quantity
- 728 vials
- Company
- Innoveix Pharmaceuticals Inc, Addison, TX
- Distribution
- Nationwide within the United States
- Initiated
- July 9, 2021 · Voluntary: Firm initiated
- Classified
- July 20, 2021
- Reported
- July 28, 2021
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.